Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 36, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2023-04-17
DOI
10.1128/cmr.00059-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of daptomycin therapeutic drug monitoring on clinical outcomes: a systematic review
- (2023) Kelly A. Cairns et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination
- (2022) Yu-Chung Chuang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin
- (2022) Yu-Chung Chuang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- risk factors for persistent enterococcal bacteremia: a multicenter retrospective study.
- (2022) Linda Bussini et al. Journal of Global Antimicrobial Resistance
- Eosinophilic Syndromes Associated With Daptomycin Use: Re-exposure Hypersensitivity Pneumonitis and Prior Peripheral Eosinophilia
- (2022) Katelyn A West et al. Open Forum Infectious Diseases
- Impact of infectious diseases consultation on the outcome of patients with enterococcal bacteremia: a systematic literature review and meta-analysis
- (2022) Joseph Tholany et al. Open Forum Infectious Diseases
- Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
- (2022) Bin Lin et al. Frontiers in Public Health
- Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection
- (2022) Yu-Chung Chuang et al. BIOMEDICINE & PHARMACOTHERAPY
- Short-course versus long-course antibiotic treatment for uncomplicated vancomycin-resistant enterococcal bacteraemia: a retrospective multicentre cohort study
- (2022) Christina Bahrs et al. CLINICAL MICROBIOLOGY AND INFECTION
- Ring-fused 2-pyridones effective against multidrug-resistant Gram-positive pathogens and synergistic with standard-of-care antibiotics
- (2022) Taylor M. Nye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity
- (2021) S. Luque et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection
- (2021) Laura Soldevila-Boixader et al. Antibiotics-Basel
- Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: Availability, performance and barriers to implementation
- (2021) Indy Sandaradura et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Contezolid: First Approval
- (2021) Sheridan M. Hoy DRUGS
- Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series
- (2021) Alessandro Russo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Optimizing antimicrobial use: challenges, advances and opportunities
- (2021) Timothy M. Rawson et al. NATURE REVIEWS MICROBIOLOGY
- Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
- (2021) George Sakoulas et al. Open Forum Infectious Diseases
- Increasing Trend of Vancomycin-resistant Enterococci Bacteremia in a Tertiary Care Hospital of South India: A Three-year Prospective Study
- (2021) Anitha Gunalan et al. Indian Journal of Critical Care Medicine
- The COVID-19 pandemic: a threat to antimicrobial resistance containment
- (2021) Raspail C Founou et al. Future Science OA
- Combination Therapy of Chloramphenicol and Daptomycin for the Treatment of Infective Endocarditis Secondary to Multidrug Resistant Enterococcus faecium
- (2021) Sunish Shah et al. HOSPITAL PHARMACY
- Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010–2019)
- (2021) Cecilia G. Carvalhaes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020
- (2021) Simon Brinkwirth et al. Eurosurveillance
- Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
- (2021) Yuki Hanai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical impact of vancomycin‐resistant enterococci colonization in nonliver solid organ transplantation and its implications for infection control strategies: A single‐center, 10‐year retrospective study
- (2021) Alexandra C. McFarlane et al. Transplant Infectious Disease
- A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals
- (2021) Athena L.V. Hobbs et al. Journal of Global Antimicrobial Resistance
- 1243. Eravacycline in Bacteremia: A Case Series
- (2021) Justin A Andrade et al. Open Forum Infectious Diseases
- Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)
- (2021) German A Contreras et al. Open Forum Infectious Diseases
- Real-Time Therapeutic Drug Monitoring (TDM)-Based Pharmacokinetic/Pharmacodynamic (PK/PD) Optimization of Complex Antimicrobial Therapy in a Critically Ill Morbidly Obese Patient. Grand Round/A Case Study
- (2020) Pier Giorgio Cojutti et al. THERAPEUTIC DRUG MONITORING
- In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient
- (2020) Eric Wenzler et al. Open Forum Infectious Diseases
- Early Experience with Eravacycline for Complicated Infections
- (2020) S Alosaimy et al. Open Forum Infectious Diseases
- Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model
- (2020) Seyedehameneh Jahanbakhsh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Accumulation of Major Linezolid Metabolites in Patients with Renal Impairment
- (2020) Ernane Souza et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting
- (2020) Ouli Xie et al. BMC INFECTIOUS DISEASES
- How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
- (2020) A.-G. Märtson et al. CLINICAL MICROBIOLOGY AND INFECTION
- Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
- (2020) J. Turnidge et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
- (2020) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections
- (2020) Kathryn R. Dalton et al. Antimicrobial Resistance and Infection Control
- Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients
- (2020) Laurens Manning et al. Open Forum Infectious Diseases
- Stopping the Routine use of Contact Precautions for Management of MRSA and VRE at Three Academic Medical Centers: An Interrupted Time Series Analysis
- (2020) Sarah Haessler et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus
- (2020) Jatinder Kaur et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
- (2020) Takashi Ueda et al. BMC Pharmacology & Toxicology
- Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia
- (2020) Waqas Aslam et al. AMERICAN JOURNAL OF THERAPEUTICS
- Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care–Associated Infections in Australia: A Retrospective Case-cohort Study
- (2020) X J Lee et al. CLINICAL INFECTIOUS DISEASES
- Streptogramins for the treatment of infections caused by Gram-positive pathogens
- (2020) Sophie Reissier et al. Expert Review of Anti-Infective Therapy
- Teicoplanin and therapeutic drug monitoring: An update for optimal use in different patient populations
- (2020) Federico Pea JOURNAL OF INFECTION AND CHEMOTHERAPY
- The Frequency of, and Factors Associated with Prolonged Hospitalization: A Multicentre Study in Victoria, Australia
- (2020) Richard Ofori-Asenso et al. Journal of Clinical Medicine
- Thirty years of VRE in Germany – “expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci
- (2020) Guido Werner et al. DRUG RESISTANCE UPDATES
- Resistance in Vancomycin-Resistant Enterococci
- (2020) William R. Miller et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex
- (2020) John Merlino et al. PATHOLOGY
- Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies
- (2020) Vanessa Grant-Di Felice et al. Surgical Infections
- Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases
- (2019) Sarah Weber et al. ANNALS OF HEMATOLOGY
- Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study
- (2019) Genovefa A Papanicolaou et al. CLINICAL INFECTIOUS DISEASES
- Utilizing genomic analyses to investigate the first outbreak of van A vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility
- (2019) Abby P. Douglas et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates
- (2019) Jonathan B. Mandell et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Eravacycline: A Review in Complicated Intra-Abdominal Infections
- (2019) Lesley J. Scott DRUGS
- The Enterococcus: a Model of Adaptability to Its Environment
- (2019) Mónica García-Solache et al. CLINICAL MICROBIOLOGY REVIEWS
- Reply to Cheng and Chuang
- (2019) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- The Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?
- (2019) George H Talbot et al. CLINICAL INFECTIOUS DISEASES
- Correction to: Eravacycline: A Review in Complicated Intra-Abdominal Infections
- (2019) Lesley J. Scott DRUGS
- Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin
- (2019) Samira Dahesh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbiology and Preclinical Review of Omadacycline
- (2019) James A Karlowsky et al. CLINICAL INFECTIOUS DISEASES
- Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy
- (2019) Si-Ho Kim et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Prevalence of Infective Endocarditis in Enterococcus faecalis Bacteremia
- (2019) Anders Dahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genomics of vancomycin-resistant Enterococcus faecium
- (2019) Claire Gorrie et al. Microbial Genomics
- Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
- (2019) Pier Giorgio Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Determining therapeutic trough ranges for linezolid
- (2019) Abdullah Alsultan SAUDI PHARMACEUTICAL JOURNAL
- Observational retrospective single‐centre study in Japan to assess the clinical significance of serum daptomycin levels in creatinine phosphokinase elevation
- (2019) Motozumi Ando et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice
- (2019) Gauri G Rao et al. THERAPEUTIC DRUG MONITORING
- Impact of Enterococcal Bacteremia in Liver Transplant Recipients
- (2019) Youn Jeong Kim et al. TRANSPLANTATION PROCEEDINGS
- Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis
- (2019) Changcheng Shi et al. Journal of Global Antimicrobial Resistance
- Impact on mortality of a bundle for the management of enterococcal bloodstream infection
- (2019) Michele Bartoletti et al. Open Forum Infectious Diseases
- The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections
- (2019) Mark Redell et al. Open Forum Infectious Diseases
- Economic evaluation of vancomycin-resistant enterococci (VRE) control practices: a systematic review
- (2019) C. MacDougall et al. JOURNAL OF HOSPITAL INFECTION
- Observational study to determine the optimal dose of daptomycin based on pharmacokinetic/pharmacodynamic analysis
- (2019) Tomoyuki Yamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Efficacy of Daptomycin Monotherapy and In Combination with β-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect
- (2018) Razieh Kebriaei et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests
- (2018) Shelley A. Campeau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Statin Coadministration on the Risk of Daptomycin-Associated Myopathy
- (2018) Ryan K Dare et al. CLINICAL INFECTIOUS DISEASES
- Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases
- (2018) J. Rello et al. CLINICAL MICROBIOLOGY AND INFECTION
- Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium
- (2018) Vidthiya Menon et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Combatting resistant enterococcal infections: a pharmacotherapy review
- (2018) Nicholas J Mercuro et al. EXPERT OPINION ON PHARMACOTHERAPY
- Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature
- (2018) Yoshitsugu Higashi et al. INTERNAL MEDICINE
- Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections
- (2018) David B. Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review
- (2018) Farnaz Foolad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
- (2018) Yu-Chung Chuang et al. Scientific Reports
- Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
- (2018) Laura Puchter et al. Antimicrobial Resistance and Infection Control
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
- (2018) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli
- (2018) Ryan L. Crass et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Current use of daptomycin and systematic therapeutic drug monitoring: clinical experience in a tertiary care institution
- (2018) Alicia Galar et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Omadacycline: A New Tetracycline Antibiotic
- (2018) John A. Dougherty et al. ANNALS OF PHARMACOTHERAPY
- MIC-based dose adjustment: facts and fables
- (2017) Johan W Mouton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Attributable mortality of hospital-acquired bloodstream infections in Ireland
- (2017) M. Brady et al. JOURNAL OF HOSPITAL INFECTION
- The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
- (2017) Jian Wang et al. Annals of Clinical Microbiology and Antimicrobials
- Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in anIn VitroPharmacokinetic-Pharmacodynamic Model
- (2016) Ashley D. Hall Snyder et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study)
- (2016) J. Brad Wiggers et al. BMC INFECTIOUS DISEASES
- Influence of Minimum Inhibitory Concentration in Clinical Outcomes ofEnterococcus faeciumBacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
- (2016) Bhavarth S. Shukla et al. CLINICAL INFECTIOUS DISEASES
- Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients
- (2016) Nicholas S. Britt et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose
- (2016) Y.-C. Chuang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fosfomycin
- (2016) Matthew E. Falagas et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel
- (2016) Joe Pardo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- Therapeutic drug management of linezolid: a missed opportunity for clinicians?
- (2016) Dario Cattaneo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis
- (2016) Ming Zhao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Oral pristinamycin for the treatment of resistant Gram-positive infections in patients with cancer: Evaluation of clinical outcomes
- (2016) J.C. Teng et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Variable linezolid exposure in ICU patients—possible role of drug-drug interactions
- (2016) Christoph Töpper et al. THERAPEUTIC DRUG MONITORING
- Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5
- (2016) Pengjuan Gong et al. VIROLOGY
- Tedizolid for Treatment of Enterococcal Bacteremia
- (2016) Praveen Sudhindra et al. Open Forum Infectious Diseases
- Colonization with Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection among Patients with Malignancy: A Systematic Review and Meta-Analysis
- (2016) Michail Alevizakos et al. Open Forum Infectious Diseases
- β-Lactams Enhance Daptomycin Activity against Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium inIn VitroPharmacokinetic/Pharmacodynamic Models
- (2015) Jordan R. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?
- (2015) Federico Pea et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
- (2015) Larry M. Baddour et al. CIRCULATION
- Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic
- (2015) Steven D. Burdette et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
- (2015) Pamela A. Moise et al. CLINICAL THERAPEUTICS
- Correlation between pharmacokinetic/pharmacodynamic indices and clinical outcomes in Japanese patients with skin and soft tissue infections treated with daptomycin: analysis of a phase III study
- (2015) Yoshio Takesue et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- 2015 ESC Guidelines for the management of infective endocarditis
- (2015) Gilbert Habib et al. EUROPEAN HEART JOURNAL
- VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis
- (2015) Chatura Prematunge et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials
- (2015) N. Eliakim-Raz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- -Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
- (2015) J. R. Smith et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy
- (2015) Moshe C. Ornstein et al. LEUKEMIA & LYMPHOMA
- Therapeutic Drug Monitoring of Daptomycin
- (2015) Claudine Reiber et al. THERAPEUTIC DRUG MONITORING
- Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2015) Taeksun Song et al. EBioMedicine
- Prolonged use of oritavancin for vancomycin-resistantEnterococcus faeciumprosthetic valve endocarditis
- (2015) Jennifer A. Johnson et al. Open Forum Infectious Diseases
- MRSA and VRE Colonization in Solid Organ Transplantation: A Meta-Analysis of Published Studies
- (2014) P. D. Ziakas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impact of Different Antimicrobial Therapies on Clinical and Fiscal Outcomes of Patients with Bacteremia Due to Vancomycin-Resistant Enterococci
- (2014) Kayoko Hayakawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penetration of Daptomycin into Bone and Synovial Fluid in Joint Replacement
- (2014) D. Montange et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Daptomycin or Linezolid in Combination with Rifampin or Gentamicin against Biofilm-Forming Enterococcus faecalis or E. faecium in anIn VitroPharmacodynamic Model Using Simulated Endocardial Vegetations and anIn VivoSurvival Assay Using Galleria mellonella Larvae
- (2014) Megan K. Luther et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
- (2014) Yu-Chung Chuang et al. BMC INFECTIOUS DISEASES
- Prosthetic Joint Infection
- (2014) A. J. Tande et al. CLINICAL MICROBIOLOGY REVIEWS
- Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight
- (2014) Takashi Niwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
- (2014) H.-Y. Dong et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study
- (2014) J.A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia
- (2013) Eleni P. Balli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream Infections
- (2013) Donald W. Whang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
- (2013) Chung-Chih Lai et al. BMC INFECTIOUS DISEASES
- Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization
- (2013) A.A.Y. Cheah et al. CLINICAL MICROBIOLOGY AND INFECTION
- A Current Perspective on Daptomycin for the Clinical Microbiologist
- (2013) R. M. Humphries et al. CLINICAL MICROBIOLOGY REVIEWS
- Tigecycline: an update
- (2013) Gary E. Stein et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia
- (2013) F. Pea et al. INFECTION
- Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections
- (2013) Antonello Di Paolo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Genomic analysis of teicoplanin resistance emerging during treatment of vanB vancomycin-resistant Enterococcus faecium infections in solid organ transplant recipients including donor-derived cases
- (2013) Natasha E. Holmes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
- (2013) R. Kullar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
- (2013) Y. Nukui et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Long-Term Carriage of Vancomycin-Resistant Enterococci in Patients Discharged from Hospitals: a 12-Year Retrospective Cohort Study
- (2013) S. Karki et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Stewardship Approach for Optimizing Antimicrobial Therapy through Use of a Rapid Microarray Assay on Blood Cultures Positive for Enterococcus Species
- (2013) A. Sango et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety and Effectiveness of Daptomycin Across a Hospitalized Obese Population: Results of a Multicenter Investigation in the Southeastern United States
- (2013) P. Brandon Bookstaver et al. PHARMACOTHERAPY
- Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in anIn VitroPharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2012) Ashley D. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis
- (2012) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin SynergyIn Vitrowith Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents
- (2012) Jillian L. Descourouez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital
- (2012) Kyung Mok Sohn et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations
- (2012) B. T. Tsuji et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
- (2012) F. Pea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The rise of the Enterococcus: beyond vancomycin resistance
- (2012) Cesar A. Arias et al. NATURE REVIEWS MICROBIOLOGY
- Vancomycin-resistant Enterococcus faecium meningitis in adults: Case series and review of the literature
- (2012) Bettina M. Knoll et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
- (2011) Federico Pea et al. ANNALS OF PHARMACOTHERAPY
- Therapeutic drug monitoring of antimicrobials
- (2011) Jason A. Roberts et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia
- (2011) T. Peel et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms
- (2011) A. Holmberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Pristinamycin for Infections by Gram-Positive Bacteria: Clinical Experience at an Australian Hospital
- (2010) A. B. Reid et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
- (2010) Sujata M. Bhavnani et al. CLINICAL INFECTIOUS DISEASES
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Quinupristin–dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: Efficacy and development of resistance
- (2010) Yong Pil Chong et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE
- (2010) John B. Bossaer et al. SUPPORTIVE CARE IN CANCER
- Multidrug-Resistant Enterococcus faecium Endocarditis Treated with Combination Tigecycline and High-Dose Daptomycin
- (2009) Amanda C Schutt et al. ANNALS OF PHARMACOTHERAPY
- Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus: Importance of Combination with Rifampin
- (2009) A.-K. John et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Peptide Nucleic Acid Fluorescent In Situ Hybridization for Hospital-Acquired Enterococcal Bacteremia: Delivering Earlier Effective Antimicrobial Therapy
- (2008) G. N. Forrest et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence and management of drug-resistant enterococcal infections
- (2008) Cesar A Arias et al. Expert Review of Anti-Infective Therapy
- Renal function as a predictor of linezolid-induced thrombocytopenia
- (2008) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline
- (2008) S. H. Zinner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pristinamycin as adjunctive therapy in the management of Gram-positive multi-drug resistant organism (MDRO) osteoarticular infection
- (2008) N. Ruparelia et al. JOURNAL OF INFECTION
- Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
- (2007) K. M. Erlandson et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now